A5054707530- COVID-19 Clinical Research Studies
- Palliative Care and End-of-Life Issues
- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- Antifungal resistance and susceptibility
- Nursing Roles and Practices
- Cancer survivorship and care
- Healthcare Quality and Management
- Childhood Cancer Survivors' Quality of Life
- Drug-Induced Adverse Reactions
- Economic and Financial Impacts of Cancer
- Global Health Workforce Issues
- Antibiotic Use and Resistance
- Autoimmune Neurological Disorders and Treatments
- Salivary Gland Tumors Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Patient-Provider Communication in Healthcare
- Family and Patient Care in Intensive Care Units
- Myasthenia Gravis and Thymoma
- Breast Implant and Reconstruction
- Antibiotics Pharmacokinetics and Efficacy
- Clostridium difficile and Clostridium perfringens research
- Leech Biology and Applications
- Cancer Diagnosis and Treatment
- Primary Care and Health Outcomes
Rutgers, The State University of New Jersey
2021-2022
Olivia Newton-John Cancer Wellness & Research Centre
2021
Austin Health
2021
SUNY Downstate Health Sciences University
2020
State University of New York
2020
Western Health
2018
Sunshine Hospital
2018
Australian National University
2012
COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of fungal infections, including candidemia following severe though understanding factors clinical outcomes remains unclear.To describe characteristics, among patients hospitalized COVID-19.A multicenter, case-control study was conducted to evaluate in who developed between August 2020 2021.Chart review evaluating institutional patient...
Abstract Background Nurses are becoming increasingly important as providers of primary health care in A ustralia. In November 2010, M edicare provider rights and P harmaceutical B enefits S cheme for nurse practitioners, working private practice collaboration with a medical practitioner, were introduced Although international evidence suggests that practitioners would be appropriate acceptable at the first point contact, such care, there is little ustralian about what consumers willing to...
Abstract Background Thirty‐day mortality after chemotherapy has been suggested as a marker of quality in oncology care. Retrospective audits worldwide have put this figure at between 8.1% and 43%, with previous retrospective Australian putting 3.4% 18%. To date, there not prospective cohort study patients receiving palliative intent an day unit. Aim The aim the is to benchmark 30‐day for identify associated factors tertiary cancer centre. Methods results A all diagnosis malignancy referred...
Abstract Purpose To describe challenges in the management of prophylaxis against infections for patients receiving medicinal leech therapy given changes antimicrobial resistance patterns normal flora leeches. Summary This article presents a patient case reconstructive surgery complicated by infection associated with use leeches, as well discussion therapy, focusing on considerations choosing prophylactic agent. Conclusion Our report highlights Aeromonas isolates leeches and potential...
Available studies are lacking in analysis of baseline demographics and hospital presentation patients at risk expiring due to coronavirus disease 2019 (COVID-19), particularly Black American patients. We conducted a retrospective chart review determine similarities among who expired COVID-19 an academic medical center Brooklyn, New York.This is observational study 200 complications COVID-19. Patients were included this if they had laboratory-confirmed SARS-CoV-2 infection during their...
Abstract Background In patients receiving palliative care, medical interventions are transitioned away from aggressive and curative attempts to less invasive more comfort measures. Antimicrobial usage remains a challenging subject in care decisions, where many physicians focus on reduction of patient pain discomfort, without consideration for adverse effects such as the development antimicrobial resistance or patient-specific drug events. With limited data benefit, we aimed assess use at end...
Abstract Background Available studies are lacking in analysis of baseline demographics and hospital presentation patients at risk expiring due to coronavirus disease 2019 (COVID-19), particularly Black American patients. We conducted a retrospective chart review determine similarities among who expired COVID-19 an academic medical center Brooklyn, New York. Study design methods This is observational study 200 complications COVID-19. Patients were included this if they had...
Abstract Background Available studies are lacking in analysis of baseline demographics and hospital presentation patients at risk expiring due to coronavirus disease 2019 (COVID-19), particularly Black American patients. We conducted a retrospective chart review determine similarities among who expired COVID-19 an academic medical center Brooklyn, New York. Study design methods This is observational study 200 complications COVID-19. Patients were included this if they had...
Abstract Background COVID-19 can cause serious illness requiring multimodal treatment of the viral infection and its associated complications, including potential for secondary infections. Studies have suggested an increased risk fungal infections, candidemia following severe though understanding factors clinical outcomes remains unclear. Methods A multi-center, case-control study patients with was conducted to evaluate in who developed between August 2020 2021. Risk mortality were...
Abstract Background Daptomycin (DAP) has become an appealing treatment option for gram-positive infections, which are common in patients receiving hemodialysis (HD), due to frequent access and manipulation. The approved DAP dosing of 4 6 mg/kg every 48 hours (q48h) quickly becomes desynchronized from the patient’s HD schedule requires burden additional IV access. Previous pharmacokinetic studies have suggested that can be dosed three-times weekly following HD, but no evaluated clinical...